Ignite Creation Date:
2024-05-06 @ 7:30 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02545283
Status:
TERMINATED
Last Update Posted:
2022-01-11
First Post:
2015-08-31
Brief Title:
A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia AML
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-31
First Submit QC Date:
September 8 2015
Study First Post Date:
2015-09-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-09-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-28
Last Update Post Date:
2022-01-11
Last Update Post Date Type:
ACTUAL